TCP1 alpha/CCTA anticorps (full length)

N° du produit ABIN7879121

Cet anticorps Souris Monoclonal détecte spécifiquement TCP1 alpha/CCTA dans IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour TCP1 alpha/CCTA anticorps (full length) (ABIN7879121)

Antigène: TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp TCP1 alpha/CCTA est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: TP63-2427

Détail du produit anti-TCP1 alpha/CCTA anticorps

Épitope: full length

Fonction: p63 Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogène: Full length human recombinant protein was used as the immunogen for the p63 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the p63 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the p63 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur TCP1 alpha/CCTA

Antigène: TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Autre désignation: p63

Sujet: P63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands, however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90 % . Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80 %. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts.

UniProt: Q9H3D4